These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8410631)
41. Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid. Swanson DL; Pittelkow MR; Benson LM; Hawkridge AM; Muddiman DC Arch Dermatol; 2005 Jun; 141(6):801-3. PubMed ID: 15967944 [No Abstract] [Full Text] [Related]
42. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel. Uner M; Wissing SA; Yener G; Müller RH Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122 [TBL] [Abstract][Full Text] [Related]
47. Principles and criteria in the development and optimization of topical therapeutic products. Shah VP; Behl CR; Flynn GL; Higuchi WI; Schaefer H Pharm Res; 1992 Aug; 9(8):1107-11. PubMed ID: 1357648 [No Abstract] [Full Text] [Related]
48. New drug information. Acanya. JAAPA; 2009 Apr; 22(4):12. PubMed ID: 19452815 [No Abstract] [Full Text] [Related]
49. Topical devices for atopic dermatitis: what is the data behind these new products? Bergstrom KG J Drugs Dermatol; 2007 Sep; 6(9):956-8. PubMed ID: 17941371 [No Abstract] [Full Text] [Related]
50. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Tanghetti EA; Popp KF Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364 [TBL] [Abstract][Full Text] [Related]
51. [Purpura after application of a eutectic mixture of local anesthetic]. Cervigón I; Torres-Iglesias LM; Palomo A Actas Dermosifiliogr; 2008; 99(6):499-500. PubMed ID: 18558068 [No Abstract] [Full Text] [Related]
52. Topical therapy for psoriasis. Lebwohl M; Abel E; Zanolli M; Koo J; Drake L Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153 [No Abstract] [Full Text] [Related]
53. Proposal and pharmacotechnical study of a modern dermo-pharmaceutical formulation for cold cream. Jiménez Soriano MM; Fresno Contreras MJ; Sellés Flores E Boll Chim Farm; 1996 Jun; 135(6):364-73. PubMed ID: 8942063 [TBL] [Abstract][Full Text] [Related]
54. A new approach to comparing efficacy results from clinical trials of topical acne vulgaris treatments. Bikowski J J Drugs Dermatol; 2007 Jul; 6(7):688-92. PubMed ID: 17763591 [TBL] [Abstract][Full Text] [Related]
55. Novel topical drug delivery systems and their potential use in acne vulgaris. Taglietti M; Hawkins CN; Rao J Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713 [TBL] [Abstract][Full Text] [Related]
56. Treatment of perioral dermatitis with topical pimecrolimus. Rodríguez-Martín M; Sáez-Rodríguez M; Carnerero-Rodríguez A; Rodríguez-García F; Cabrera de Paz R; Sidro-Sarto M; Guimerá F; Sánchez R; García-Bustínduy M; Noda-Cabrera A J Am Acad Dermatol; 2007 Mar; 56(3):529-30. PubMed ID: 17317501 [No Abstract] [Full Text] [Related]
57. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Ting WW; Vest CD; Sontheimer RD Int J Dermatol; 2004 Jul; 43(7):538-47. PubMed ID: 15230899 [No Abstract] [Full Text] [Related]
58. [Topical corticosteroids in dermatology--advantages and side effects]. Wojas-Pelc A; Setkowicz M; Bogdaszewska-Czabanowska J Przegl Lek; 2002; 59(3):170-4. PubMed ID: 12184032 [TBL] [Abstract][Full Text] [Related]